Cohort as Part of Undergraduate Medical Studies at the University of Sherbrooke

January 2, 2026 updated by: Université de Sherbrooke

The main goals of this project are to support the research training of undergraduate medical students at the University de Sherbrooke and promote planning of health services a better knowledge of the prevalence, social, and geographic distribution of public health issues in several regions in Quebec.

To meet the objectives of the project, a population-based prospective study linked to several regions in Quebec public health surveys is proposed.

Monitoring and data collection will be provided by 3rd year undergraduate medical students at University de Sherbrooke through telephone interviews.

The research themes will be proposed by various researchers affiliated with the University de Sherbrooke. They will be selected yearly by an internal scientific committee and included in the questionnaires administered by the students.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

6000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Canada
    • Quebec
      • Sherbrooke, Quebec, Canada, J1H 5N4
        • Recruiting
        • Centre Hospitalier Universitaire de Sherbrooke, departement de médecine
        • Contact:
        • Principal Investigator:
          • Paul Farand, MD MSc
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The target population is everyone who has been diagnosed with covid-19 in several regions in Quebec

Description

Inclusion criteria:

  • Participants will have been diagnosed with covid-19 between November 2020 and May 2021;
  • Place of residence: province of Quebec.

Exclusion criteria :

- Unfit adults.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Estrie CIUSSS
Subjects from the Estrie's Integrated Health and Social Services Centre
Other: No intervention
No intervention
Saguenay-Lac-Saint-Jean CIUSSS
Subjects from the Saguenay-Lac-Saint-Jean's Integrated Health and Social Services Centres
Other: No intervention
No intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health questionnaire
Time Frame: Once a year through study completion.

General health questionnaire including questions about lifestyle, access to health services, comorbidities, mental health, alcohol and drugs consumption. Additional questions regarding more specific themes (Lyme disease, medical aid in dying, COVID-19, etc.) will be added or adapted yearly.

Most of the questions are individually based on previously accepted or previously used questionnaires and thus, the health questionnaire used in this project does not include a specific scale of measurement for each subjects.
Once a year through study completion.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Université de Sherbrooke

Investigators

  • Principal Investigator: Paul Farand, MD MSc, Université de Sherbrooke

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 29, 2019

Primary Completion (Estimated)

August 1, 2030

Study Completion (Estimated)

September 1, 2030

Study Registration Dates

First Submitted

March 6, 2019

First Submitted That Met QC Criteria

April 24, 2019

First Posted (Actual)

April 26, 2019

Study Record Updates

Last Update Posted (Estimated)

January 7, 2026

Last Update Submitted That Met QC Criteria

January 2, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • MP-31-2019-3172

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe